Dr. Curley earned his medical degree at The University of Texas Medical School at Houston in 1982 and completed his residency at The University of New Mexico Hospitals, Albuquerque, NM. In 1990, he concluded his Surgical Oncology Fellowship at MD Anderson Cancer Center. Dr. Curley joined the Michael E. DeBakey Department of Surgery in January 2014.
Dr. Curley specializes in providing surgical care for patients with hepatobiliary and pancreatic malignancies. His research has involved the design, bench testing, preclinical testing, and clinical testing of two FDA-approved devices for invasive radiofrequency ablation needles to treat unresectable liver cancers.
Dr. Curley's translational research has focused on testing a novel noninvasive radiofrequency (RF) field treatment device. This device is coupled with targeted delivery of metallic or semiconducting nanoparticles that release heat under RF field induction to cause thermal cytotoxicity in cancer cells. His group has also performed complex physicochemical measurements of the nanoparticles, and has conjugated them to antibodies, peptides, and pharmacologic agents to target them on cancer cells.
Dr. Curley is chief of the Division of Surgical Oncology, Olga Keith Wiess Chair of Surgery and associate director for clinical affairs for the Dan L. Duncan Cancer Center at Baylor College of Medicine as well as professor of Mechanical Engineering and Materials Science at Rice University.